
Alignment Healthcare (ALHC) Stock Forecast & Price Target
Alignment Healthcare (ALHC) Analyst Ratings
Bulls say
Alignment Healthcare Inc. is well-positioned to capitalize on a favorable 2026 rate update, particularly as competitors reduce benefits, leveraging a significant Stars funding advantage. The company's integrated Medicare Advantage and value-based care model is expected to yield long-term market share gains and above-average growth, fostering a robust operational framework. Additionally, expected gross profit per member per month (PMPM) is projected to increase significantly, starting from $90-$150 for the first two years and progressing beyond $230 in years three to five, which underscores the potential for enhanced financial performance.
Bears say
Alignment Healthcare has demonstrated the ability to lower Average Daily Census (ADK) during a period of increased healthcare utilization, primarily influenced by post-COVID dynamics and regulatory changes. Despite operating against a publicly disclosed ADK target that signals strength in its technology and operating model, the company's valuation multiple exceeds the long-term range for peer managed care organizations, positioning it at a higher risk of valuation pressure. Furthermore, challenges related to data friction among different payors and inconsistent performance among employed or affiliated primary care providers may hinder the effectiveness of its value-based care approach, contributing to a cautious outlook on the stock.
This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Alignment Healthcare (ALHC) Analyst Forecast & Price Prediction
Start investing in Alignment Healthcare (ALHC)
Order type
Buy in
Order amount
Est. shares
0 shares